Mucormycosis risk mitigation in the COVID battle
Updated:
Updated:
May 13, 2021 23:46 IST
Diabetes control can lower the chances of dangerous side-effects in COVID-19 treatment such as this fungal infection
Share Article
AAA
Diabetes control can lower the chances of dangerous side-effects in COVID-19 treatment such as this fungal infection
The COVID-19 pandemic continues to play havoc all over the world and India is no exception to this. While 70%-80% of those affected with COVID-19 recover without many side-effects, about 20%-30% of patients affected with symptomatic COVID-19 might require hospitalisation here, a minority can get worse and require treatment in an intensive care unit (ICU). Ever since the COVID-19 pandemic was first described from Wuhan in China, it is quite clear that it is people with comorbidities such as being of an older age, obese, having uncontrolled diabetes, heart or respiratory diseases and malignancies, who fare badly.
Arthritis drug reduces death, length of stay in hospitalized COVID patients, study says
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Hydronephrosis Market 2021 Covers Global Industry Share, Size, Gross Margin, Future Trends, Demand, Business Insight by Leading Key Players Forecast till 2023
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Ultrasound in Medicine & Biology. As a result, these patients could gain quicker access to alternative colon-saving therapies.
Physicians typically administer corticosteroids to patients admitted to the hospital with severe ulcerative colitis, but about one-third of these patients don t respond to the treatment. The small pilot study showed that bowel thickness measurements on ultrasound scans may indicate which patients are more likely to need salvage therapy. The key finding was that the simple measurement of bowel wall thickness of affected colonic segments at admission provided a clear guide to subsequent failure of steroids, wrote the authors, led by Dr. Rebecca Smith, a gastroenterologist at Alfred Hospital in Melbourne, Australia.